Non-life (re)insurance stocks have continued to do well in 2019, despite an equities sell-off in July-August, but traded ILS has remained relatively moribund after the traumas of 2017-18.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: